Sign in
Taking people in United StatesEarly phase 1

Testing how glucose and fat affect blood vessels in healthy adults

Studies whether sugar and fat infusions change blood vessels in lean healthy adults.

Key facts

Who runs it
University of Kansas Medical Center
Where
Kansas City, United StatesSee the site
Trial code
Registry title
Reversing Glucose and Lipid-mediated Vascular Dysfunction
Status
Recruiting
Phase
Early phase 1
People taking part
46 people, planned
Started
9 May 2022
Expected to end
1 Aug 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Dextrose 20 % in 500 ML Injection
  • Intralipid
  • Saline
  • Ascorbic acid
Record updated
5 June 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for lean, healthy adults with normal insulin sensitivity and normal blood pressure. It studies how glucose and fat affect blood vessels and blood pressure.

Age
18 to 79 years
Sex
All sexes can join
Disease stage
No disease. The trial is looking for lean adults (BMI < 25 kg/m) with normal insulin sensitivity and blood pressure below 140 (systolic) and below 90 mmHg (diastolic).
Earlier treatment
Weight stable (+/- 5 lbs (2 kg)) for the previous 3 months. People must be willing to stop vitamin C or E supplements or omega-3 fatty acids starting 2 weeks before.
Biomarker or test result
Normal insulin sensitivity, calculated from fasting glucose and insulin levels in the blood.

Main reasons for not taking part

  • Type I or Type II diabetes mellitus
  • Current smoker or smoking in the past 3 months
  • Hyperlipidemia
  • Hypertension (>130/80 mmHg)
  • History of heart disease or vascular disease

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Lean: BMI < 25 kg/m
  • Normal insulin sensitivity: (calculation based on fasting glucose and insulin concentrations in blood)
  • Middle-aged: 18-79 years
  • Blood pressure: < 140 (systolic) and < 90 mmHg (diastolic
  • Weight stable (+/- 5 lbs) for the previous 3 months
  • Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior
  • Able and willing to provide written informed consent

Who cannot take part

  • Current smoker or History of smoking in the past 3 months
  • Hypertension: >130/80 mmHg
  • History of heart disease (e.g., myocardial infarction, stent, heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy)
  • History of vascular disease (e.g., bypass, stroke)
  • Diabetes mellitus Type I or Type II: fasting glucose < 126 mg/dL and/or HbA1c < 6.5%
  • Hyperlipidemia: Fasting triglycerides < 250 mg/dL

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 79 years old?

Where in United States

  • University of Kansas Medical CenterKansas City, United StatesContact: Seth W. W HolwerdaTaking people

About the trial

What the trial wants to find out

The purpose of our study is to understand the extent to which the blood vessels are affected by glucose and fat (lipids) in lean healthy adults and if these changes in the blood vessels contribute to the development of high blood pressure.

The 2 groups in the trial

  • Glucose InfusionTreatment being tested

    Hyperglycemia (glucose infusion) will receive an I.V. Glucose infusion with a co-infusion of ascorbic acid or placebo at your visit 2 and the alternative treatment of ascorbic acid or placebo will be given on the subsequent study visit 3.

    Treatment: Dextrose 20 % in 500 ML Injection, Saline, and Ascorbic acid

  • Lipid InfusionTreatment being tested

    Hyperlipidemia (lipid infusion) will receive an I.V. Lipid infusion with a co-infusion of ascorbic acid or placebo at your visit 2 and the alternative treatment of ascorbic acid or placebo will be given on the subsequent study visit 3.

    Treatment: Intralipid, Saline, and Ascorbic acid

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Reversing Glucose and Lipid-mediated Vascular Dysfunction (REGAL)
Plain-language title
Testing how glucose and fat affect blood vessels in healthy adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04832009, who can take part
Record updated
5 June 2025